The lipids from three types of organisms-a Proteus mirabilis wild type highly resistant to polymyxin B, a polymyxin B-sensitive mutant derived from the wild type, and the wild type grown in the presence of sulfadiazine resulting in phenotypic conversion to polymyxin B sensitivity-were examined to determine the nature of polymyxin B resistance. The phospholipid compositions were nearly identical; each organism contained similar small amounts of N-methyl phosphatidylethanolamine in addition to comparable quantities of phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin. The fatty acid compositions were similar in the exponential phase of growth; in the stationary phase, sulfadiazine markedly inhibited the synthesis of cyclopropane fatty acids. Liposomes prepared from the dried lipids of the three types of organisms were extensively and similarly disrupted by the polymyxin. These findings suggest that polymyxin B resistance in P. mirabilis is determined by the cell envelope which prevents access of the antibiotic to the susceptible lipid target sites.
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Among the Enterobacteriaceae, only Proteus species and Serratia marcescens are regularly resistant to the lethal action of the polymyxin antibiotics (7, 14, 15) . Since the bactericidal action of the polymyxins likely results from interaction of the antibiotic with phosophate groups of the cell envelope (cell wall and cytoplasmic membrane) phospholipids (11) , two mechanisms to explain polymyxin resistance are possible. The lipids in the cell envelope may be intrinsically resistant to polymyxin-induced damage, or the target lipids may not be accessible to the polymyxins in the resistant bacteria.
To distinguish between these alternatives, we examined both the lipid composition and the susceptibility to polymyxin B of liposomes (lipid spherules in aqueous suspension) prepared from the lipids isolated from three organisms with various polymyxin B sensitivities: a Proteus mirabilis highly resistant to the antibiotic, a polymyxin B-sensitive mutant isolated from the wild type, and a wild type organism grown in the presence of sulfadiazine which results in phenotypic conversion to polymyxin B sensitivity (8, 13) .
The nature of the dramatic sulfonamide-induced changes in P. mirabilis resulting in susceptibility to the polymyxins is not known. Sulfadiazine, by interfering with one-carbon transfer reactions, may alter bacterial lipids by inhibiting the methylation of phosphatidylethanolamine or the formation of cyclopropane fatty acids. It is known, for example, that methylated phosphatidylethanolamines are regularly found in some Proteus species (6) and that phosphatidylcholine does not bind polymyxin B, whereas phosphatidylethanolamine does (4 (2) .
Acid hydrolysis was performed at 100 C for 4 hr in 1 N HCI in sealed ampoules. The hydrolysates were extracted twice with petroleum ether, and the aqueous phases were evaporated to dryness. The residues were dissolved in small volumes of distilled water. Descending chromatography was done with the solvent system phenol-N-butyl alcohol-formic acid (80%)-water (50:50:3:10, w/v/v/v), saturated with solid KCI and Whatman no. 1 paper which had previously been dipped into 1 N KCI and dried. The spots were revealed on exposure of the chromatograms to ninhydrin spray.
Fatty acid analysis. The hydrolysis of phospholipids and methylation of fatty acids was accomplished by using 20% sulfuric acid in methanol (3). The fatty acid methyl esters were extracted in hexane, dried under nitrogen, and dissolved in benzene. Gas-liquid chromatography was performed in a Packard gasliquid chromatograph with a 6-ft ethylene-glycol succinate column in an isothermic run at 180 C. for removal of free 42K. The column was eluted with the Tris-saline buffer and the eluate was collected in 1-mI volumes. The spherule fraction, evident by the presence of turbidity, came out in tubes 9 through 13. The tubes were counted in a gamma counter (NuclearChicago Corp.), and the fractions showing the highest activity (which coincided with the peak of turbidity)
Preparation of lipid spherules (liposomes
were pooled. The pooled suspension was divided into two equal volumes; to one, polymyxin B (1 jg/ml) was added. Both were then dialyzed against Tris buffer in saline over a period of 6 hr. At intervals, the bags were transferred to fresh buffer. The bags were finally opened, and the contents were assayed for radioactivity along with samples of the dialysate. 
RESULTS
Polymyxin B sensitivity and sulfadiazine synergy. Table 1 shows the effect of 10 ,ug of polymyxin B per ml on the viability of growing cultures of the two polymyxin B-sensitive mutants of P. mirabilis. Within 10 min of exposure to polymyxin B, the number of viable bacteria decreased more than 10,000-fold. There was no lysis apparent, and treated cells did not appear significantly different from the controls by phase microscopy. The wild-type P. mirabilis cells were not killed by 150 Mg of polymyxin B per ml ( Table 2) .
The synergistic action of sulfadiazine and polymyxin B on the strain of P. mirabilis used in this study is demonstrated (Table 2 ). Polymyxin B alone had no effect on the growth of the organism. Sulfadiazine retarded the rate of growth, but the culture eventually achieved a concentration of 1010 cells/ml at stationary phase, as did the control. For the first 2 hr, the culture containing sulfadiazine and polymyxin B behaved like the culture containing sulfadiazine alone; however, by 3 hr, the bactericidal action of polymyxin B became apparent. The addition of p-amino benzoic acid at 0.5 mg/ml abolished the bactericidal activity of the polymyxin in the presence of sulfadiazine.
Phospholipid composition. The radiochromatogram scans of the 82P-labeled deacylated products obtained by alkaline hydrolysis of lipids from the three organisms were similar (Fig. 1) . By comparison with published RF values (2), the fastest moving peaks were identified as glyceryl-phosphoryl esters of N-methylethanolamine and ethanolamine. The peaks after them have the mobilities in this solvent system of the deacylated products of phosphatidyl glycerol (double peak) and cardiolipin.
The presence of ethanolamine and its N-methyl derivative in the three types of lipids was confirmed by paper chromatography of products of acid hydrolysis. The hydrolysate of each lipid gave two spots when sprayed with ninhydrin, with RF values of 0.12 and 0.38 which corresponded with the RF values of the standard ethanolamine (0.13) and N-methyl-ethanolamine (0.38). Thus, although a small quantity of the mono-methyl ester of phosphatidylethanolamine is present in P. mirabilis, the polymyxin B-sensitive mutant and the sulfadiazine-treated bacteria contain similar amounts. Furthermore, the phospholipid profiles of the three organisms are nearly identical, making it unlikely that modification in phospholipids is responsible for differences in polymyxin B sensitivity.
The fatty acid composition of lipids prepared from bacteria in the exponential phase and stationary phase of growth is shown in Table 3 . The fatty acids present in the growing cells of the wild type, the mutant, and the wild type exposed to sulfadiazine were essentially similar, both qualitatively and quantitatively. The fatty acid patterns of the stationary-phase cells are entirely different. The untreated organisms show a marked decrease in the C16 fatty acids, the appearance of significant amounts of cyclopropane acids, and the appearance of two unidentified, slow-moving acids designated as A and B. The fatty acid composition of the sulfonamide-treated bacteria in stationary phase is strikingly different; little cyclopropane acid is present, and the two unidentified peaks are absent. Hence, sulfonamide treatment markedly alters the fatty acid composition in stationary phase; the composition of all three types of growing cells is so similar, however, that it is unlikely that fatty acid changes account for the varying susceptibility to polymyxin B.
Effect of polymyxin B on liposomes. Figure 2 shows the effect of polymyxin B on the permeability of lipid spherules prepared from lipids extracted from the three types of organisms. The spherules were prepared in aqueous suspension, as described, and contained trapped 42K. In all three types, polymyxin B disrupted the spherules, resulting in a rapid leakage of the radioactivity; in the first 2 hr, 70 to 90% of the label had leaked out as compared to 10 to 30% in the controls. Thus, artificial membranes formed from lipids of polymyxin-resistant and -sensitive organisms were both profoundly affected by the antibiotic. DISCUSSION Newton (11) and Few (4) have presented compelling evidence that the polymyxins are bactericidal because of their interaction with ionized phosphate groups of phospholipids in the membranes of the bacterial cell envelope resulting in "disorganization" of the membrane structure. When Few (4) examined the interaction of polymyxin E with monolayers of various phospholipids, he observed that the antibiotic bound to and penetrated phosphatidylethanolanine monolayers, whereas it had no effect on phosphatidylcholine monolayers. Few suggested that the positively charged choline group shielded the phospholipid phosphate from the reactive amino groups of the polymyxin. Since Proteus is one of the few bacterial species which contains methylated phosphatidylethanolamines (6), we hypothesized that the presence of this phospholipid might be responsible for polymyxin resistance. The methylation of phosphatidylethanolamine, with S-adenosyl methionine as methyl donor, is one pathway for methylated ethanolamine biosynthesis in microorganisms (9, 16) , and, hence, the phenotypic conversion of P. mirabilis to polymyxin B sensitivity caused by growth in sulfadiazine might be explained by a sulfonamideinduced block in the synthesis of methylated phosphatidylethanolamine. This does not appear to be the case since the phospholipids of the wild type, the mutant, and the sulfadiazine-treated bacteria are nearly identical (Fig. 1 ). All the organisms contain similar small amounts of N-methyl ethanolamine.
Since S-adenosylmethionine is also the methyl donor for the synthesis of cyclopropane fatty acids (12) and the nature of the fatty acids in phospholipids could influence their interaction with polymyxin B, we examined the fatty acid content of the three types of organisms (Table 3) .
Indeed, sulfadiazine markedly inhibited cyclo-POLYMYXIN B RESISTANCE propane fatty acid synthesis in P. mirabilis, but significant amounts of the cyclopropane acids were only found in stationary-phase bacteria. In growing bacteria, the fatty acid compositions were almost identical in all three organisms. Hence, it is not likely that modification of phospholipid fatty acids influences polymyxin B susceptibility.
Further confirmation that changes in lipid composition are not responsible for polymyxin B sensitivity in the P. mirabilis mutants or after exposure of the wild type to sulfadiazine is afforded by our observation on the susceptibility of liposomes to polymyxin B. Those prepared from the lipids of both sensitive and resistant Proteus strains were extremely susceptible to permeability alterations caused by the antibiotic. This is another strong argument against the hypothesis that resistance to polymyxin B is a function of the lipid composition of the bacteria.
If the lipids are not the important determinants of sensitivity and resistance to the polymyxins in these organisms, then the accessibility of the antibiotic to the lipids must be. While this work was in progress, Teuber (19) reported that penicillin-induced spheroplasts of P. mirabilis were lysed by polymyxin B, whereas the intact organisms were resistant to the bactericidal effect. This finding also suggests that the cell wall of these organisms prevents access of polymyxin B to the cytoplasmic membrane. A related interpretation is that it is not the wall per se, but rather some compound present in the periplasmic space, which is released on spheroplast formation, that prevents the bactericidal action of polymyxin B. Lieve (10) observed that treatment of Escherichia coli with ethylenediaminetetraacetic acid in Tris fosters penetration of actinomycin D into the bacteria; Taubeneck (18) reported that spheroplast formation of P. mirabilis converts the bacteria from erythromycin resistance to sensitivity. It is of interest that our polymyxin-sensitive mutants of P. mirabilis and the sulfadiazinetreated organisms remain resistant to both actinomycin D and erythromycin (unpublished data). Thus, the lesion in the mutant and that caused by sulfadiazine does not result in a generally increased permeability in the cell wall, since neither actinomycin D nor erythromycin can enter these bacteria. The aspect of the cell wall responsible for polymyxin B resistance is not known. It appears likely that the synthesis of some component is defective in the polymyxin-sensitive mutants of P. mirabilis and that its synthesis is inhibited by sulfonamide. Studies are under way to define cell wall differences in the three types of organisms.
We observed that trimethoprin [2,4-diamino-5-(3',4',5'-trimethoxyl-benzyl) pyrimidine], an inhibitor of dihydrofolate reductase, also converts P. mirabilis (unpublished data) and S. marcescens (7) to polymyxin B sensitivity. The combination of sulfonamide or trimethoprin, or both, both inhibitors of the synthesis of tetrahydrofolate, with a polymyxin may be effective therapy for infections with a wide variety of gram-negative infections, including those caused by Proteus and Serratia. It may be of practical importance to identify the nature of the cell wall factor responsible for polymyxin B resistance in Proteus since it is likely that other inhibitors of the factor exist-inhibitors which may not be antibacterial per se, but which sensitize Proteus and Serratia to polymyxin B, resulting in effective combination antim-crobial therapy.
